Novo Nordisk said that patients taking a pill form of Wegovy in a clinical trial lost about as much weight as those who get the shot version, fueling new optimism that oral GLP-1 drugs could expand an ...
Novo Nordisk (NVO) presented data from a sub-analysis of the phase 3 REDEFINE 1 trial at the European Association for the Study of Diabetes congress 2025 from 15-19 September in Vienna, Austria. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback